PharmaCyte Biotech Statistics
Total Valuation
PMCB has a market cap or net worth of $8.89 million. The enterprise value is -$8.14 million.
Important Dates
The last earnings date was Monday, March 17, 2025, after market close.
Earnings Date | Mar 17, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
PMCB has 6.89 million shares outstanding. The number of shares has decreased by -35.50% in one year.
Current Share Class | 6.89M |
Shares Outstanding | 6.89M |
Shares Change (YoY) | -35.50% |
Shares Change (QoQ) | -8.87% |
Owned by Insiders (%) | 2.84% |
Owned by Institutions (%) | 11.49% |
Float | 6.17M |
Valuation Ratios
The trailing PE ratio is 0.97.
PE Ratio | 0.97 |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.21 |
P/TBV Ratio | 0.22 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.20
Current Ratio | 14.20 |
Quick Ratio | 14.03 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 42.89% and return on invested capital (ROIC) is -5.96%.
Return on Equity (ROE) | 42.89% |
Return on Assets (ROA) | -4.89% |
Return on Invested Capital (ROIC) | -5.96% |
Return on Capital Employed (ROCE) | -10.56% |
Revenue Per Employee | n/a |
Profits Per Employee | $4.99M |
Employee Count | 2 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.57% in the last 52 weeks. The beta is -0.53, so PMCB's price volatility has been lower than the market average.
Beta (5Y) | -0.53 |
52-Week Price Change | -45.57% |
50-Day Moving Average | 1.62 |
200-Day Moving Average | 1.76 |
Relative Strength Index (RSI) | 32.32 |
Average Volume (20 Days) | 14,755 |
Short Selling Information
The latest short interest is 26,759, so 0.39% of the outstanding shares have been sold short.
Short Interest | 26,759 |
Short Previous Month | 14,684 |
Short % of Shares Out | 0.39% |
Short % of Float | 0.43% |
Short Ratio (days to cover) | 1.17 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -4.50M |
Pretax Income | -1.14M |
Net Income | 9.98M |
EBITDA | n/a |
EBIT | -4.50M |
Earnings Per Share (EPS) | $1.29 |
Full Income Statement Balance Sheet
The company has $16.76 million in cash and n/a in debt, giving a net cash position of $16.76 million or $2.43 per share.
Cash & Cash Equivalents | 16.76M |
Total Debt | n/a |
Net Cash | 16.76M |
Net Cash Per Share | $2.43 |
Equity (Book Value) | 40.25M |
Book Value Per Share | 5.83 |
Working Capital | 15.77M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -2.27M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |